-
Meet the speakers
Chaired by Dr Howard Fillit, Chief Science Officer Alzheimer's Drug Discovery Fund and Dr Stacie Weninger President of FBRI, this virtual dialogue will explore the different experiences, and the lessons from that, of companies and funders innovating in the biomarker field. With opening remarks from Randall Bateman, Charlotte Teunissen, Michael Weiner and Henrik Zetterberg followed by a roundtable discussion for all participants in the dialogue.
-
Read the agenda
Read the agenda for the dialgoue on innovations in biomarkers the World Dementia Council is hosting on Friday 31 October
-
Roundtable CTAD
Hosted by Dr Joanne Pike, Chair of the World Dementia Council and President & CEO of the Alzheimer’s Association. This working lunch brought together global leaders, researchers, and industry experts to explore innovation in clinical trials and the development of treatments for Alzheimer’s disease and other dementia. The lunch occured during CTAD 2026 held in San Diego.
There have been major, and rapid, advances in the development of biomarkers for Alzheimer's disease and other forms of dementia. This virtual workshop brings together international experts to explore the lessons from that rapid innovation and the challenges and opportunities to advancing progress.
Format
Expert presentations will kick off the event, offering insights into biomarker innovations and their potential to transform diagnosis, treatment and research. This will be followed by a roundtable discussion where all participants are encouraged to share their thoughts and perspectives.
Output
This is the first workshop convened by the World Dementia Council exploring innovation in dementia. The overall programme will inform a paper for Alzheimer’s & Dementia. Participation is by invitation only.
Date: Friday October 31 2025
Time: 1100-1230 EST / 1500-1630 GMT / 1600-1730 IST
Platform: Zoom
For more information on participating in the meeting please contact info@worlddementiacouncil.com